Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 399 entries
View as:

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00536601 Org: User:
Start: 06/29/06 End: 07/09/18 Due: 07/09/19

Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03297489 Org: User:
Start: 11/06/17 End: 02/15/21 Due: 02/15/22

Nicotine Vapor Specific Sensory Measurement

Phase: N/A Priority: Normal
NCT ID: NCT04533542 Org: User:
Start: 03/10/21 End: 03/07/23 Due: 03/07/24

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02227940 Org: User:
Start: 01/08/15 End: 02/12/19 Due: 02/12/20

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00470067 Org: User:
Start: 02/28/07 End: 12/31/09 Due: 12/31/10

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00849186 Org: User:
Start: 08/31/07 End: 04/30/10 Due: 04/30/11

Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02048943 Org: User:
Start: 03/31/15 End: - Due: -

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT06733350 Org: User:
Start: 01/15/25 End: 01/15/29 Due: 01/15/30

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05539365 Org: User:
Start: 02/01/25 End: 02/01/27 Due: 02/01/28

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT06306638 Org: User:
Start: 10/01/24 End: 10/01/29 Due: 10/01/30

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00524589 Org: User:
Start: 04/30/06 End: 09/30/10 Due: 09/30/11

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06343376 Org: User:
Start: 11/26/24 End: 06/15/29 Due: 06/15/30

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

Phase: N/A Priority: Normal
NCT ID: NCT04231539 Org: User:
Start: 02/18/20 End: 08/18/24 Due: 08/18/25

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT06350500 Org: User:
Start: 12/15/24 End: 11/01/26 Due: 11/01/27

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02965976 Org: User:
Start: 12/30/16 End: 04/28/22 Due: 04/28/23

Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00248495 Org: User:
Start: 06/08/05 End: 04/05/17 Due: 04/05/18

Weight Loss Interventions for Black Adults of Faith

Phase: N/A Priority: Normal
NCT ID: NCT04557540 Org: User:
Start: 09/25/21 End: 12/07/22 Due: 12/07/23

Effect of a Low Glycemic Index Diet on Breast Density

Phase: N/A Priority: Normal
NCT ID: NCT01237938 Org: User:
Start: 03/31/06 End: - Due: -

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT06256718 Org: User:
Start: 05/24/23 End: 04/30/27 Due: 04/30/28

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02955290 Org: User:
Start: 12/22/16 End: 12/09/27 Due: 12/09/28

Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers

Phase: N/A Priority: Normal
NCT ID: NCT04060446 Org: User:
Start: 06/06/19 End: 03/02/20 Due: 03/02/21

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Phase: N/A Priority: Normal
NCT ID: NCT06821997 Org: User:
Start: 06/01/25 End: 03/01/27 Due: 03/01/28

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04379518 Org: User:
Start: 11/17/20 End: 11/17/23 Due: 11/17/24

Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00970203 Org: User:
Start: 09/30/09 End: 10/05/19 Due: 10/05/20

Consumer Assessment of Tobacco Flavor and Odor

Phase: N/A Priority: Normal
NCT ID: NCT04358315 Org: User:
Start: 04/03/23 End: 12/09/25 Due: 12/09/26